Cipta Sarana Medika Tbk. vs Magna Investama Mandiri Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.29M 24h volume), while Magna Investama Mandiri Tbk. trades at Rp100 (market cap 351.35B, 12.47M 24h volume). The key difference: Magna Investama Mandiri Tbk. is far larger — about 2.2× Cipta Sarana Medika Tbk.'s market cap, and Magna Investama Mandiri Tbk. is more actively traded (12.47M versus 3.29M). Which is the better fit depends on your goals.
| DKHH | MGNA | |
|---|---|---|
Market Cap | 163.22B | 351.35B |
Volume | 3.29M | 12.47M |
Lot | 32.94K | 124.74K |
Turnover | 209.87M | 1.31B |
Average Price | 63.7 | 105.15 |
Value | 209.87M | 1.31B |
Indicative Equilibrium Price | 64 | 107 |
Indicative Equilibrium Volume | 110.6K | 774 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Magna Finance Tbk (the Company) formerly PT Arkasa Utama Leasing was established based on Notarial Deed No. 10 dated March 09, 1984 of James Jacinta Susanti, S.H.
Read more on MGNA →